Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
brutal. just amazed endless selling at this level.
if you are right, then you would have never bought a single share of RVNC past year - $30s to $2.6... if your data was that accurate. so either data isn't or you have not bought any shares because of such insight.
in 99% of cases w/ shorts, they do NOT have more info than we have. usually even less info. it's more technical analysis/charts, or sentiments, or competitive threats, etc. every stock has shorts. every buyout stocks had shorts who were nuked b/c they "didn't" have any more/better info. it isn't a major issue here. farthest from being a top 10 issue
anyone know when China may approve Daxi through our partner? been 11 months now. seems awful long. anyone know average time for Chinese authority to approve ? i thought maybe average of 12 mo or 1 yr?
there are no "data" to track as investor? other than anecdotal, word of mouth, one or few direct contacts w/ injectors, instagram potss, etc. so what data are you talking about other than these?
3$ lasted one day. but still think we have seen bottom at $2.6. anecdotal signs on social media/IG and my wife who takes daxi seem to be progressing. no idea if they can beat sales forecasts but $2.8 stock price doesn't do justice for the product.
we have 2 investor conference in June. any longer term investors know how Foley is w/ these conferences? usually non event or does he tend to deliver some positives in these conf?
sorry. my bad. $2.6s.. geez.. 3.6 be 40% higher i guess. i take that of course..
is it possible to hold here in 3.6s.. 3-4 days now... amazing how low bar my wishes have become.. hold the $3.6 line seems like i am routing for some clinical microcap bio.
you don't need Dew to tell you Foley is no A+ CEO. stock price tells you that, along with prior decisions to jack up Dax pricing. but honestly it's not just CEO. there is a BOD. all public co's do. they have power to change C levels. they chose not to. the collective mind of BOD has chosen to stick w/ Foley. But as it is w/ biz, the support won't last forever for any one in that position. i surmise that BOD and all of us are giving a bit more time for turnaround. if not, Foley won't be around
this is a dumb take. companies change CEOs all the time - even Apple (Jobs got fired and came back of course). asking for ceo change doesn't mean investors just sell the stock. more often than not, new leadership and visions are needed (not abandoning the company altogether). I fully agree Foley should have been fired. zero reason to keep him no matter what some of the posters here including Dewey has said. the mistakes he has made are more than worthy of being fired.
now, since BOD has not fired Foley, I don't go around posting something that isn't going to happen. I now need to see the implementation of turnaround that is prob. a multi-quarter development. I am giving 2 more quarters to see it.
russel rebalance initial notification today? after hours? anyone know?
yahoo estimates for 2024 is $276M (slightly lower than co's 280M). where do you see $250M forecast? don't think that's the case.
unlikely. xbi and many small bio's crushed last few days. rvnc no different AND has horrendous technical / chart which makes it worse.
yea.. prob. tutes (some) are forced to sell here.. sub $3 close two days in a row.
can't get any worse than another $2.6 more down.... so that's that
50k shares total now. avg around 2.95$. wish i had waited longer to buy first few tranches. but have no idea if we are near bottom. 2 mo. to go for ER which may or may not be good. and not expecting any news to lift our shares. but to me, sub $3 has high r/r scenario
added 10k $2.76
agree. never seen a stock like this in one year. $30s to $2.92. insane amount of selling. i do think daytraders exacerbates it. short interest is not low but far from being toxic. only way this gets going is some + news and gaps up a dollar and runs w/ shorts covering fueling it more.. and then ER beat/raise. that is only way
stock price aside, execs have to retain good sales people. imagine if "these" performers left merely b/c of stock price is in the gutter. and mgmt have to join them on the expensive trip. it is what it is. their total expenses are so hefty, this is hardly the main problem w/ cost side. we need 1) hit revenue targets and beat them consistently (i.e. multiple Qs). 2) continue to manage costs and over time, reduce them dramatically. do both next few quarters, we will be in teens.
yes. and there is nothing wrong w/ it. my company does similar for top sales people. you need them and they need to be rewarded, motivated. that is hardly the problem here.
i would like to see more insider buys at this level. c-levels. it's barely $3. unless SEC reg. prevents them from buying at the moment
1) investors and market concern for debt convertibles.
2) cannot do any more offerings.
3) cannot miss revenue estimates
4) accelerate lowering expenses further. still way too heavy on expenses for sub $500M company
no one believes Foley. not analysts. not investors. surely not shorts. this is not a one time event to turnaround, but he needs to earn trust. communicate progress more often. lessen debt/financing concerns we all have
40k shares @ 3.13 average. been swing trading mostly for few months (slight loss) but now holding for 2-3 QTRs or more. just want to give summer and 2 ERs (next two), before adding or exiting at loss.. love the product, hate the mgmt. EOLS is certainly not more valuable than RVNC (fact). at this rate, at some pt, hostile takeover will occur. bankruptcy fears on twitter unjustified.
Q1 is never a good qtr for most bioland stocks. don't expect that to be diff here. and ceo has said so in prior comments. i think key is keeping the same 2024 overall guidance even w/ soft q1 #s (which i expect). and maybe, just maybe in Q2 or Q3 ER, they can actually beat the guidance and/or raise 2024 overall #s. that would be something. i don't think Q1 # by itself means much as long as overall 2024 # is in tact or even higher than $280 guidance.. (of course if lower guidance, then sure, we will lose even the $3 handle maybe), but i am here for 4-6 qtrs as this will take a lot of time to play out
w/ RVNC, not a stock you want to be watching tick by tick every day. that will make LT holders suicidal. i have been in RVNC for years (did exit a couple of times too), and recently entered, and I knew this would be a very long turnaround, if at all. i think we get Q1 ER out of the way (nothing special prob.) and need to see Q2 and Q3 to be the pivot point to turn this around. usually before that happens, share price would have bottomed well beforehand. i think 3.7 today would turn out to be the bottom.
why do you think they raised. they didn't need to...
i think we will know the reason in a day or two when this offering is closed. we need to find out who got into this offering before we judge.
- did ceo/insiders buy into offering as we had hoped for once blackout period was over. i certainly expected ceo to buy significant # of shares post ER. maybe this was one way.
- maybe one or more tutes wanted to get in w/ discount
- maybe the offering price is healthier level than just $6. maybe 6.5. maybe $7. we will know soon
i m not sure if this offering is all gloom and doom. i suspect CEO and/or other execs would get into this offering at lower price. and/or other funds. we will see soon. they didn't need to do this for sure, so why? maybe some individuals/execs/funds want to get in at this level. that's more likely
100M offering. did they really need to raise here? wonder why now at barely $7? do tutes or insiders want to get in at cheaper prices?
i would hope CEO buys some shares here post ER. i think 3 days post ER, execs can buy some shares. if he doesn't at sub $7, i be shocked. i recall he bought some in the teens a while back before run up to $30. i will be looking for this next week.
nice dip pre market for s1 filing. amazed still people react to those.
honestly, this is going to take few quarters to really gain any traction on a noticeable level. the mishaps can be fixed for sure, with the best product (imagine if RVNC product was shit and trying to adjust biz model). I think by Q2 ER this should be more evident. and if they are going to beat and raise their lower guidance, it prob will be Q2 and Q3 and Q4. Not Q1. Market looks 6 mo. ahead. I think we prob grind here in the 5-6-7$ range until next ER. after Q2 ER in August, if I am right, we should be double digit. In 12 mo. I still think we regain $15+ range. End game is still sell the co. I have been following for 5 years and still really like this co. Not the CEO but it is what it is.
nice spike in AH despite miss. seems like shorts covering into the ER.
when is ER? anyone
what's happened to RVNC lately? worse than those 20M microcap co's trading lower and lower. ENTA has been crushed... 2 stocks that should do better than typical bios, imo.
don't see any material news, so have to assume just the sentiment for RVNC.
yes. the market is open tday
maybe. prob. but hard to say given how weak XBI has been and enta volume has been very modest.
hard to assess fair value for ENTA at this time, coupled w/ bio meltdown. very disappointing to say the least
Yea I thought of that but at this SUB 1B Enter. Value, should Covid program (regardless of results) have such a decimating impact on the valuation?
I had thought given the royalty stream and cash level, of all bio land, ENTA would hold up better than others, but it actually has been worse or at least as bad as other small/med bios
Anyone has an idea why ENTA has been so weak lately? more so than most bios which have been hammered. ER should not have had this kind of impact.
honestly, they have a golden desirable most superior product out there with potential demand from all over the world who are self absorbed w/ their appearance...
shameful that it has taken so long to get to this point and MC that hasn't moved in years. my money has been sitting here for years. Don't think of CEO much, but if he can't get this to finish line and sell the co. for 4B+, he's a fool.